【英語タイトル】Hormone Replacement Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
	・商品コード：IMARC23FE0023 ・発行会社（調査会社）：IMARC ・発行日：2023年2月1日 ・ページ数：121 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール ・調査対象地域：グローバル ・産業分野：医療

The global hormone replacement therapy market size reached US$ 8.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 12.4 Billion by 2028, exhibiting a growth rate (CAGR) of 6.26% during 2023-2028.

Hormone replacement therapy (HRT) is used for replenishing the hormones that are present in low levels in the human body. This treatment is particularly favourable for patients with growth hormone deficiency, women nearing menopause and elderly people suffering from hypogonadism. HRT is available in several forms such as skin and mouth patches (transdermal), gels, injections and implants. However, HRT may not be suitable for patients who have a history of blood clots, liver disease and untreated high blood pressure. This therapy may also include some adverse effects like bloating, swelling, nausea, leg cramps, headaches, indigestion, increased cholesterol levels and a rise in the number of red blood cells.

A surge in the incidences of hormone imbalance disorders in the geriatric and neonatal populations is primarily driving the market growth. The rising need for new treatment options with better safety results is further boosting the demand for (HRT) hormone replacement therapy. Additionally, aggressive marketing and direct selling campaigns by the key players along with the development of new gel-based formulations creates an attractive market for these therapies. Moreover, increasing awareness among the consumers and the presence of regularly monitored formulations are some of the other drivers stimulating the growth of the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global hormone replacement therapy market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on product, route of administration and type of disease.

Breakup by Product:

Estrogen Replacement Therapy
Human Growth Hormone Replacement Therapy
Thyroid Replacement Therapy
Testosterone Replacement Therapy
Others

Based on product, estrogen replacement therapy accounts for the majority of the market share. Other types include human growth hormone replacement therapy, testosterone replacement therapy, thyroid replacement therapy and others.

Breakup by Route of Administration:

Oral
Parenteral
Transdermal

On the basis of route of administration, the report has segmented the market on the basis of oral, parenteral and transdermal segments.

Breakup by Type of Disease:

Menopause
Hypothyroidism
Male Hypogonadism
Growth Hormone Deficiency
Others

On the basis of disease, the report has segmented the market on the basis of menopause, hypothyroidism, male hypogonadism, growth hormone deficiency and others.

Breakup by Region:

North America
Europe
Asia Pacific
Middle East and Africa
Latin America

Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Amongst these, North America is the largest market, accounting for the majority of the market share.

Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Bayer AG, Eli Lilly & Company, Roche, Hisamitsu Pharmaceutical Co. Inc., Merck, Mylan, Novartis, Novo Nordisk and Pfizer.

This report provides a deep insight into the global hormone replacement therapy market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the hormone replacement therapy market in any manner.

Key Questions Answered in This Report
1. What was the size of the global hormone replacement therapy market in 2022?
2. What is the expected growth rate of the global hormone replacement therapy market during 2023-2028?
3. What are the key factors driving the global hormone replacement therapy market?
4. What has been the impact of COVID-19 on the global hormone replacement therapy market?
5. What is the breakup of the global hormone replacement therapy market based on the product?
6. What is the breakup of the global hormone replacement therapy market based on the route of administration?
7. What is the breakup of the global hormone replacement therapy market based on the type of disease?
8. What are the key regions in the global hormone replacement therapy market?
9. Who are the key players/companies in the global hormone replacement therapy market?